Aptevo Therapeutics Raises $3 Million Through Warrant Exercise
Aptevo Therapeutics (APVO) has successfully entered into warrant inducement letter agreements with specific holders of its outstanding common warrants. Under these agreements, the warrant holders have agreed to exercise their positions in full for cash. The transaction is expected to generate approximately $3 million in gross proceeds for the company. This capital infusion provides additional liquidity to support Aptevo's ongoing operations and strategic initiatives.
Tickers: $APVO
Topics: capital raising equity financing warrants